Sunmax Biotechnology Co Ltd Cash Flow Quality Index
Sunmax Biotechnology Co Ltd cash flow quality index. Sunmax Biotechnology Co Ltd (4728) has a Cash Flow Quality Index of 0.85x as of September 2025. Operating cash flow of NT$160.84 Million is below net income of NT$189.68 Million, suggesting accrual-heavy earnings not yet converted to cash. See 4728 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Sunmax Biotechnology Co Ltd (2016–2024)
Cash flow quality index of Sunmax Biotechnology Co Ltd from 2016 to 2024. Historical Cash Flow Quality Index for Sunmax Biotechnology Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 4728 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Sunmax Biotechnology Co Ltd Cash Flow Quality Index by Year (2016–2024)
Sunmax Biotechnology Co Ltd cash flow quality index by year from 2016 to 2024. Year-by-year earnings quality comparison for Sunmax Biotechnology Co Ltd. For the full cash flow conversion analysis, see how efficiently does Sunmax Biotechnology Co Ltd generate cash.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | NT$397.37 Million | NT$679.40 Million | ▼ -37.3% |
| 2023 | 0.93x | NT$848.56 Million | NT$909.39 Million | ▲ +45.2% |
| 2022 | 0.64x | NT$342.97 Million | NT$533.83 Million | ▼ -5.6% |
| 2021 | 0.68x | NT$243.28 Million | NT$357.49 Million | ▼ -40.6% |
| 2020 | 1.15x | NT$386.97 Million | NT$337.76 Million | ▼ -60.2% |
| 2019 | 2.88x | NT$289.51 Million | NT$100.45 Million | ▲ +113.4% |
| 2018 | 1.35x | NT$100.83 Million | NT$74.66 Million | ▼ -39.8% |
| 2017 | 2.24x | NT$37.09 Million | NT$16.54 Million | ▼ -76.4% |
| 2016 | 9.51x | NT$16.58 Million | NT$1.74 Million | — |